Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Encodia
AddedFeb 17, 2024
UpdatedJun 18, 2026
Encodia

Encodia

Encodia, a private biotech firm, revolutionizes proteomics with scalable protein analysis via ProteoCode technology.

HQ
San Diego, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Encodia, founded as a privately held biotechnology company, aims to revolutionize proteomics by making protein analysis highly scalable and accessible. Their core mission is to accelerate innovations in human health through their patented ProteoCode technology, which enables detailed protein sequencing via a user-friendly benchtop instrument. Encodia's market focus includes researchers and institutions involved in large-scale biological studies, particularly those integrating multiomic approaches.

Notable figures affiliated with Encodia include leading experts in biotechnology and proteomics, although specific names are not provided. The company has achieved significant milestones with its ProteoCode technology, which scales easily to population-level studies and integrates seamlessly with other multiomic data. Encodia's impact lies in its potential to drive forward scientific research and healthcare innovations by providing deeper insights into protein functions and interactions.

Encodia - Similar Companies

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

Codetta logo

Codetta

codettabio.com

Encoded Therapeutics logo

Encoded Therapeutics

ActivSignal logo

ActivSignal

activsignal.com

Range Biotechnologies logo

Range Biotechnologies

range.bio

Proteios Technology logo

Proteios Technology

proteios.com

ProteoWise logo

ProteoWise

proteowise.com

Key Proteo logo

Key Proteo

keyproteo.com

Seer logo

Seer

seer.bio

PrognomiQ logo

PrognomiQ

prognomiq.com

Entwine Bio logo

Entwine Bio

entwine.bio

Ecto logo

Ecto

ecto.com

Protein Dynamic Solutions logo

Protein Dynamic Solutions

pdsbio.com

Quantum-Si logo

Quantum-Si

quantum-si.com

Proteotech logo

Proteotech

Encodia - Quick Facts

Who are Encodia's competitors?

Companies similar to Encodia include Glyphic Biotechnologies, Codetta, Encoded Therapeutics and ActivSignal.

When was Encodia founded?

Encodia was founded in 2015.

Where is Encodia's headquarters located?

Encodia's headquarters is located in San Diego, CA, US.

When was Encodia's last funding round?

Encodia's most recent funding round was for $75M (USD) in January 2021.

How much has Encodia raised to-date?

As of Jan 27, 2021, Encodia has raised a total of $75M (USD).

How many employees does Encodia have?

Encodia has 69 employees as of Feb 4, 2024.

Encodia - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Protein Analysis
Tags
  • Healthtech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software